Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Borg

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Life Sciences in Space Research|January 26, 2025
Sex-specific effects on the heart from combined exposure to simulated galactic cosmic radiation and hindlimb unloadingA S Nemec-Bakk, V Sridharan, J S Willey, et al.
Environmental Research|April 30, 2024
Does diet quality moderate the long-term effects of discrete but extreme PM<sub>2.5</sub> exposure on respiratory symptoms? A study of the Hazelwood coalmine fireThara Govindaraju, Martin Man, Alice J Owen, et al.
American Journal of Human Genetics|February 17, 2001
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effectsM Periquet, C Lücking, J Vaughan, et al.
Medicina (Kaunas, Lithuania)|November 27, 2024
Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer's Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMGB1 SignallingHemat A Elariny, Ahmed M Kabel, Heba Mohammed Refat M Selim, et al.
British Journal of Cancer|December 3, 2011
The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancerD Goldstein, N Spry, M M Cummins, et al.
Translational Psychiatry|July 27, 2012
Basal ganglia dysfunction in OCD: subthalamic neuronal activity correlates with symptoms severity and predicts high-frequency stimulation efficacyM-L Welter, P Burbaud, S Fernandez-Vidal, et al.
Revue Neurologique|September 27, 2021
Validation of a non-motor fluctuations questionnaire in Parkinson's diseaseF Faggianelli, A Loundou, K Baumstarck, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2010
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporinsM E A de Kraker, M Wolkewitz, P G Davey, et al.
BMC Cancer|May 19, 2026
A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trialE Banken, M Borg, I E G van Hellemond, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Life Sciences in Space Research|January 26, 2025
Sex-specific effects on the heart from combined exposure to simulated galactic cosmic radiation and hindlimb unloadingA S Nemec-Bakk, V Sridharan, J S Willey, et al.
Environmental Research|April 30, 2024
Does diet quality moderate the long-term effects of discrete but extreme PM<sub>2.5</sub> exposure on respiratory symptoms? A study of the Hazelwood coalmine fireThara Govindaraju, Martin Man, Alice J Owen, et al.
American Journal of Human Genetics|February 17, 2001
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effectsM Periquet, C Lücking, J Vaughan, et al.
Medicina (Kaunas, Lithuania)|November 27, 2024
Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer's Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMGB1 SignallingHemat A Elariny, Ahmed M Kabel, Heba Mohammed Refat M Selim, et al.
British Journal of Cancer|December 3, 2011
The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancerD Goldstein, N Spry, M M Cummins, et al.
Translational Psychiatry|July 27, 2012
Basal ganglia dysfunction in OCD: subthalamic neuronal activity correlates with symptoms severity and predicts high-frequency stimulation efficacyM-L Welter, P Burbaud, S Fernandez-Vidal, et al.
Revue Neurologique|September 27, 2021
Validation of a non-motor fluctuations questionnaire in Parkinson's diseaseF Faggianelli, A Loundou, K Baumstarck, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2010
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporinsM E A de Kraker, M Wolkewitz, P G Davey, et al.
BMC Cancer|May 19, 2026
A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trialE Banken, M Borg, I E G van Hellemond, et al.
Pageof 19